BLCO Logo

Bausch + Lomb Corporation (BLCO) 

NYSE
Market Cap
$7.05B
Sector
Healthcare
Industry
Medical—Instruments & Supplies
Rank in Sector
180 of 966
Rank in Industry
11 of 49

Largest Insider Buys in Sector

BLCO Stock Price History Chart

BLCO Stock Performance

About Bausch + Lomb Corporation

Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, and dry eye. The Ophthalmic Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of eye conditions, such as glaucoma, ocular hypertension, and retinal diseases; and contact lenses for therapeutic use. The Surgical segment provides tools and technologies for the treatment of cataracts, and vitreous and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices. The company was founded in 1853 and is headquartered in Vaughan, Canada.

Insider Activity of Bausch + Lomb Corporation

Over the last 12 months, insiders at Bausch + Lomb Corporation have bought $505,067 and sold $0 worth of Bausch + Lomb Corporation stock.

On average, over the past 5 years, insiders at Bausch + Lomb Corporation have bought $505,067 and sold $1.35B worth of stock each year.

Highest buying activity among insiders over the last 12 months: SAUNDERS BRENT L (CEO and Chairman of the Board) — $2.02M.

The last purchase of 32,250 shares for transaction amount of $505,067 was made by SAUNDERS BRENT L (CEO and Chairman of the Board) on 2024‑08‑05.

List of Insider Buy and Sell Transactions, Bausch + Lomb Corporation

2024-08-05PurchaseCEO and Chairman of the Board
32,250
0.0093%
$15.66$505,067+25.55%
2022-06-01Sale
9.1M
2.724%
$17.05$155.21M-1.47%
2022-05-10Sale
70M
19.4359%
$17.05$1.19B-8.60%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Fil Ltd$141.6M2.338.19M+0.86%+$1.21M0.14
GoldenTree Asset Management$81.58M1.344.72M0%+$07.14
Maple Rock Capital Partners Inc$64.79M1.063.75M0%+$04.1
ICAHN CARL C$60.55M13.5M0%+$00.54
River Road Asset Management$32.66M0.541.89M-2.59%-$867,456.590.44
Alberta Investment Management Corporation$27.54M0.451.59M+17.75%+$4.15M0.21
Citadel Advisors LLC$27.44M0.451.59M-37.72%-$16.62M0.02
Nomura Holdings$21.73M0.361.26M0%+$00.19
Whitebox Advisors$20.87M0.341.21M+29.32%+$4.73M2.38
Freshford Capital Management Llc$20.16M0.331.17M-33.57%-$10.19M3.53
Laurion Capital Management LP$17.89M0.291.03M0%+$00.13
Canada Pension Plan Investment Board$14.73M0.24851,6750%+$00.02
Clark Estates Inc Ny$10.68M0.18617,500+11.87%+$1.13M2.17
Victory Capital Management Inc$9.7M0.16560,831-2.1%-$208,274.690.01
Point72 Europe London Llp$8.77M0.14506,909New+$8.77M0.84
Point72 Asset Management$8.55M0.14494,156New+$8.55M0.01
Invenomic Capital Management LP$6.82M0.11394,067New+$6.82M0.37
Empyrean Capital Partners$6.66M0.11385,0000%+$00.52
Caspian Capital LP$5.76M0.1333,1240%+$09.37
Rokos Capital Management$5.6M0.09323,980New+$5.6M0.15
Gabelli Funds Llc$5.4M0.09312,000+3.31%+$173,000.000.04
Woodline Partners LP$5.36M0.09309,965+0.15%+$8,200.200.05
Clearline Capital LP$5.2M0.09300,651+3.68%+$184,712.130.51
Arrowstreet Capital, Limited Partnership$4.08M0.07236,142+151.16%+$2.46M<0.01
Raymond James Associates$3.67M0.06212,042+10.25%+$341,086.19<0.01
LMR PARTNERS LLP$2.59M0.04149,536-7.49%-$209,537.620.06
Ratan Capital Management LP$2.1M0.04121,4710%+$01.14
Ameriprise Financial$1.73M0.0399,725+132.32%+$982,639.71<0.0001
Allianz Asset Management Gmbh$1.73M0.03100,0000%+$0<0.01
Morgan Stanley$1.66M0.0395,931-30.05%-$712,829.07<0.0001
PDT Partners$1.27M0.0273,476+41.71%+$374,147.160.1
Brandes Investment Partners$1.08M0.0262,547-45.23%-$893,596.820.01
Bank of America$1.03M0.0259,582-49.12%-$995,079.09<0.0001
ExodusPoint Capital Management, LP$945,000.000.0254,596-62.64%-$1.58M0.01
GAMCO Investors$883,857.000.0251,090-3.95%-$36,330.000.01
Dimensional Fund Advisors$760,785.000.0143,976<0.01%-$17.30<0.0001
Susquehanna International Group$698,643.000.0140,384+279.16%+$514,380.75<0.01
Jump Financial Llc$686,256.000.0139,668-54.46%-$820,573.120.01
Wolverine Asset Management, LLC$669,146.000.0138,6790%+$00.06
Hrt Financial Llc$595,000.000.0134,441New+$595,000.00<0.01
Balyasny Asset Management Llc$625,637.000.0136,164New+$625,637.00<0.01
UBS$534,450.000.0130,893+3,644.61%+$520,177.47<0.0001
Goldman Sachs$577,837.000.0133,401-52.33%-$634,390.67<0.0001
Mariner Llc$421,047.000.0124,338+21.61%+$74,805.13<0.01
Simplex Trading Llc$417,000.000.0124,120New+$417,000.000.01
State Street$435,960.000.0125,200+34.04%+$110,720.00<0.0001
Renaissance Capital$399,215.000.0123,076+2.99%+$11,573.710.21
Nj State Employees Deferred Compensation Plan$441,150.000.0125,5000%+$00.04
Schonfeld Group$433,278.000.0125,045-89.53%-$3.7M<0.01
Fore Capital Llc$383,714.000.0122,180New+$383,714.002.39
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.